相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic Gatekeepers of Pathological B Cell Activation
Teresa Sadras et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 16, 2021 (2021)
Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis
Kenji Ohshima et al.
METABOLITES (2021)
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects againstMYCN-amplified neuroblastoma
Andrew E. Tee et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy
Jonathan Chou et al.
CANCER DISCOVERY (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?
Sarah Diab et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Acute lymphoblastic leukaemia
Florent Malard et al.
LANCET (2020)
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
Jian Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Core transcriptional regulatory circuitries in cancer
Ye Chen et al.
ONCOGENE (2020)
Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
Hua-Dong Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells In Vitro and In Vivo
Yu Zhang et al.
CLINICAL CANCER RESEARCH (2019)
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263
Tianlu Huang et al.
CELL DEATH & DISEASE (2019)
Molecular Approaches to Treating Pediatric Leukemias
Michaela Kuhlen et al.
FRONTIERS IN PEDIATRICS (2019)
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
Yuan Fang et al.
NATURE COMMUNICATIONS (2019)
A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells
Chiara Ghezzi et al.
NATURE COMMUNICATIONS (2019)
THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism
Zhu-Jun Cheng et al.
ACTA PHARMACOLOGICA SINICA (2019)
Targeting CDK7 increases the stability of Snail to promote the dissemination of colorectal cancer
Yan Zhou et al.
CELL DEATH AND DIFFERENTIATION (2019)
Interconnection between Metabolism and Cell Cycle in Cancer
Philippe Icard et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
Ali F. Abdel-Wahab et al.
PHARMACOLOGICAL RESEARCH (2019)
Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery
Robert P. Fisher
TRANSCRIPTION-AUSTIN (2019)
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies
Gang Xiao et al.
CELL (2018)
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma
Cun Wang et al.
CELL RESEARCH (2018)
Cancer Metabolism: Current Understanding and Therapies
Jessica L. Counihan et al.
CHEMICAL REVIEWS (2018)
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Waleed Minzel et al.
CELL (2018)
Analysis of redox landscapes and dynamics in living cells and in vivo using genetically encoded fluorescent sensors
Yejun Zou et al.
NATURE PROTOCOLS (2018)
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng et al.
ELIFE (2018)
CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
Wei Meng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype
Shanmugasundaram Ganapathy-Kanniappan
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Metabolic gatekeeper function of B-lymphoid transcription factors
Lai N. Chan et al.
NATURE (2017)
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival
Haizhen Wang et al.
NATURE (2017)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Florencia Cayrol et al.
NATURE COMMUNICATIONS (2017)
CDK8 Kinase Activity Promotes Glycolysis
Matthew D. Galbraith et al.
CELL REPORTS (2017)
MYC and tumor metabolism: chicken and egg
Francesca R. Dejure et al.
EMBO JOURNAL (2017)
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
Ji Liang et al.
NATURE COMMUNICATIONS (2016)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents
Yuzheng Zhao et al.
CELL METABOLISM (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Edmond Chipumuro et al.
CELL (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
分享论文
